Analyzing Amneal Pharmaceuticals (NYSE:AMRX) and PLx Pharma (NASDAQ:PLXP)
Analyzing Amneal Pharmaceuticals (NYSE:AMRX) and PLx Pharma (NASDAQ:PLXP)
Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) and PLx Pharma (NASDAQ:PLXP – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.
Amneal Pharmicals(纽约证券交易所代码:AMRX — 获取评级)和PLx Pharma(纳斯达克股票代码:PLXP — 获取评级)都是小型医疗公司,但哪只是优势股?我们将根据两家公司的风险强度、分析师建议、股息、收益、盈利能力、估值和机构所有权对比这两家公司。
Risk & Volatility
风险与波动性
Amneal Pharmaceuticals has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, PLx Pharma has a beta of 3.79, suggesting that its share price is 279% more volatile than the S&P 500.
Amneal Pharmicals的beta值为1.32,这表明其股价的波动性比标准普尔500指数高32%。相比之下,Plx Pharma的beta值为3.79,这表明其股价的波动性比标准普尔500指数高279%。
Analyst Recommendations
分析师建议
This is a breakdown of current recommendations and price targets for Amneal Pharmaceuticals and PLx Pharma, as provided by MarketBeat.
这是MarketBeat提供的Amneal Pharmicals和Plx Pharma的当前建议和目标价格的明细。
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Amneal Pharmaceuticals | 0 | 1 | 3 | 0 | 2.75 |
PLx Pharma | 0 | 2 | 0 | 0 | 2.00 |
卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
健美制药 | 0 | 1 | 3 | 0 | 2.75 |
PLx Pharm | 0 | 2 | 0 | 0 | 2.00 |
Amneal Pharmaceuticals currently has a consensus price target of $3.75, suggesting a potential upside of 107.18%. Given Amneal Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe Amneal Pharmaceuticals is more favorable than PLx Pharma.
Amneal Pharmicals目前的共识目标股价为3.75美元,表明潜在的上涨空间为107.18%。鉴于Amneal Pharmaceals更强的共识评级和更高的可能上涨空间,研究分析师显然认为Amneal Pharmace比Plx Pharma更有利。
Profitability
盈利能力
This table compares Amneal Pharmaceuticals and PLx Pharma's net margins, return on equity and return on assets.
该表比较了Amneal Pharmicals和Plx Pharma的净利润率、股本回报率和资产回报率。
Net Margins | Return on Equity | Return on Assets | |
Amneal Pharmaceuticals | -5.88% | 76.11% | 4.68% |
PLx Pharma | -606.91% | -291.11% | -119.43% |
净利润 | 股本回报率 | 资产回报率 | |
健美制药 | -5.88% | 76.11% | 4.68% |
PLx Pharm | -606.91% | -291.11% | -119.43% |
Institutional and Insider Ownership
机构所有权和内部所有权
32.8% of Amneal Pharmaceuticals shares are owned by institutional investors. Comparatively, 21.2% of PLx Pharma shares are owned by institutional investors. 26.8% of Amneal Pharmaceuticals shares are owned by insiders. Comparatively, 9.0% of PLx Pharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
32.8%的Amneal Pharmicals股份由机构投资者持有。相比之下,Plx Pharma的股票中有21.2%由机构投资者持有。26.8%的Amneal Pharmicals股票由内部人士持有。相比之下,9.0%的Plx Pharma股票由内部人士持有。强大的机构所有权表明对冲基金、大型基金经理和捐赠机构认为,从长远来看,公司的表现将优于市场。
Valuation & Earnings
估值与收益
This table compares Amneal Pharmaceuticals and PLx Pharma's top-line revenue, earnings per share (EPS) and valuation.
该表比较了Amneal Pharmicals和Plx Pharma的收入、每股收益(EPS)和估值。
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Amneal Pharmaceuticals | $2.21 billion | 0.25 | -$129.99 million | ($0.86) | -2.10 |
PLx Pharma | $4.54 million | 0.09 | -$46.13 million | ($1.85) | -0.01 |
总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
健美制药 | 22.1 亿美元 | 0.25 | -1.299 亿美元 | (0.86 美元) | -2.10 |
PLx Pharm | 454 万美元 | 0.09 | -4613 万美元 | (1.85 美元) | -0.01 |
PLx Pharma has lower revenue, but higher earnings than Amneal Pharmaceuticals. Amneal Pharmaceuticals is trading at a lower price-to-earnings ratio than PLx Pharma, indicating that it is currently the more affordable of the two stocks.
Plx Pharma的收入较低,但收益高于Amneal Pharmicals。Amneal Pharmicals的交易市盈率低于PLx Pharma,这表明它目前是这两只股票中更实惠的一只。
Summary
摘要
Amneal Pharmaceuticals beats PLx Pharma on 11 of the 14 factors compared between the two stocks.
与两只股票相比,Amneal Pharmicals在14个因素中有11个击败了PLx Pharma。
About Amneal Pharmaceuticals
关于 Amneal Ph
(Get Rating)
(获取评分)
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generic, Specialty and AvKARE Segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The AvKARE segment focuses on pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.
Amneal Pharmicals, Inc. 是一家制药公司,从事仿制药产品的开发、制造、营销和分销。它通过通用、专业和AVkare细分市场运营。Generics部门开发、制造和商业化复杂的口服固体、注射剂、眼科药物、液体、外用药物、软胶囊、吸入产品和透皮药物。专业领域向美国市场提供专有药物。AvKare部门专注于药品、医疗和外科产品,以及主要为政府机构提供的服务。该公司由钦图·帕特尔和奇拉格·帕特尔于2002年创立,总部位于新泽西州布里奇沃特。
About PLx Pharma
关于 PLx Pharma
(Get Rating)
(获取评分)
PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.
Plx Pharma, Inc. 是一家处于后期阶段的专业制药公司,从事已批准药物的技术平台的开发和商业化。它提供PLXGuard输送系统,该系统使用表面作用的脂质,例如磷脂和游离脂肪酸,通过靶向释放到胃肠道(GI)的部分来改变各种药物的物理化学特性。该公司由罗纳德·齐默尔曼于 2002 年 11 月 12 日创立,总部位于新泽西州斯巴达。
Receive News & Ratings for Amneal Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amneal Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Amneal Pharmicals Daily -在下面输入您的电子邮件地址,通过Marketbeat.com的免费每日电子邮件时事通讯接收Amneal Pharmicals及相关公司的最新新闻和分析师评级的简明每日摘要。